Bibliographic Details
| Title: |
Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study. |
| Authors: |
Adès L; Hôpital Avicenne, Université Paris, Paris, France., Boehrer S, Prebet T, Beyne-Rauzy O, Legros L, Ravoet C, Dreyfus F, Stamatoullas A, Chaury MP, Delaunay J, Laurent G, Vey N, Burcheri S, Mbida RM, Hoarau N, Gardin C, Fenaux P |
| Source: |
Blood [Blood] 2009 Apr 23; Vol. 113 (17), pp. 3947-52. Date of Electronic Publication: 2008 Nov 05. |
| Publication Type: |
Clinical Trial, Phase II; Journal Article |
| Journal Info: |
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
